A detailed history of Jacobi Capital Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Jacobi Capital Management LLC holds 6,935 shares of NVS stock, worth $682,750. This represents 0.06% of its overall portfolio holdings.

Number of Shares
6,935
Previous 6,492 6.82%
Holding current value
$682,750
Previous $691,000 15.34%
% of portfolio
0.06%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$106.13 - $120.89 $47,015 - $53,554
443 Added 6.82%
6,935 $797,000
Q2 2024

Aug 09, 2024

BUY
$92.57 - $107.37 $9,349 - $10,844
101 Added 1.58%
6,492 $691,000
Q1 2024

May 10, 2024

SELL
$95.27 - $108.47 $50,969 - $58,031
-535 Reduced 7.72%
6,391 $618,000
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $9,688 - $10,661
105 Added 1.54%
6,926 $699,000
Q2 2023

Aug 08, 2023

BUY
$92.52 - $104.91 $2,498 - $2,832
27 Added 0.4%
6,821 $688,000
Q1 2023

May 05, 2023

SELL
$80.03 - $92.81 $62,263 - $72,206
-778 Reduced 10.27%
6,794 $625,000
Q4 2022

Feb 13, 2023

BUY
$75.55 - $92.52 $9,745 - $11,935
129 Added 1.73%
7,572 $686,000
Q3 2022

Nov 09, 2022

BUY
$74.61 - $87.26 $28,575 - $33,420
383 Added 5.42%
7,443 $566,000
Q2 2022

Aug 05, 2022

BUY
$80.52 - $93.75 $131,328 - $152,906
1,631 Added 30.04%
7,060 $597,000
Q1 2022

May 06, 2022

BUY
$80.11 - $90.62 $28,759 - $32,532
359 Added 7.08%
5,429 $476,000
Q4 2021

Feb 14, 2022

BUY
$79.7 - $88.13 $13,230 - $14,629
166 Added 3.38%
5,070 $443,000
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $19,381 - $22,548
237 Added 5.08%
4,904 $401,000
Q2 2021

Aug 12, 2021

BUY
$85.24 - $94.15 $2,557 - $2,824
30 Added 0.65%
4,667 $426,000
Q1 2021

May 11, 2021

SELL
$83.5 - $98.47 $7,348 - $8,665
-88 Reduced 1.86%
4,637 $396,000
Q4 2020

Feb 08, 2021

BUY
$78.07 - $94.43 $18,034 - $21,813
231 Added 5.14%
4,725 $446,000
Q3 2020

Oct 30, 2020

BUY
$82.14 - $91.0 $8,788 - $9,737
107 Added 2.44%
4,494 $391,000
Q2 2020

Aug 04, 2020

BUY
$80.93 - $91.1 $333,269 - $375,149
4,118 Added 1530.86%
4,387 $383,000
Q2 2020

Jul 27, 2020

SELL
$80.93 - $91.1 $349,698 - $393,643
-4,321 Reduced 94.14%
269 $383,000
Q1 2020

Apr 24, 2020

BUY
$70.67 - $99.01 $57,454 - $80,495
813 Added 21.53%
4,590 $378,000
Q3 2019

Nov 12, 2019

BUY
$85.54 - $94.26 $8,725 - $9,614
102 Added 2.78%
3,777 $328,000
Q2 2019

Aug 07, 2019

BUY
$75.4 - $92.8 $25,108 - $30,902
333 Added 9.96%
3,675 $336,000
Q1 2019

May 13, 2019

BUY
$75.32 - $86.15 $14,386 - $16,454
191 Added 6.06%
3,342 $321,000
Q4 2018

Feb 11, 2019

BUY
$73.66 - $82.02 $53,108 - $59,136
721 Added 29.67%
3,151 $270,000
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $24,366 - $28,184
364 Added 17.62%
2,430 $209,000
Q2 2018

Aug 14, 2018

BUY
$64.91 - $73.36 $2,726 - $3,081
42 Added 2.08%
2,066 $156,000
Q1 2018

May 03, 2018

BUY
$70.39 - $84.15 $36,532 - $43,673
519 Added 34.49%
2,024 $161,000
Q3 2017

Nov 02, 2017

SELL
$74.14 - $77.27 $55,086 - $57,411
-743 Reduced 33.05%
1,505 $129,000
Q2 2017

Aug 10, 2017

BUY
N/A
2,248
2,248 $185,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Jacobi Capital Management LLC Portfolio

Follow Jacobi Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobi Capital Management LLC with notifications on news.